VJOncology is committed to improving our service to you

EAU 2020 | EUPROMS: prostate cancer patient-driven QoL

VJOncology is committed to improving our service to you

André Deschamps

André Deschamps, of Europa Uomo, Antwerpen, Belgium, discusses the effect of prostate cancer treatment as evaluated in the EUPROMS study, the first ever patient driven quality of life (QoL) study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics
Related videos
JAVELIN Renal 101: DepOR & outcomes in RCC
Martin Voss
Genetic risk assessment for hereditary RCC
Michael Daneshvar
Biomarkers in RCC
Martin Voss
Chemo eligibility: bladder cancer
Srikala Sridhar
Kidney cancer: post-surgery follow-up
Suzanne Merrill
Genitourinary Cancer, Prostate Cancer
EAU 2020, VJVirtual
Interview
18th July 2020
More from André Deschamps
The Europa Uomo advocacy movement
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals